Mulmit

CUMBERLAND PHARMACEUTICALS INCCUMBERLAND PHARMACEUTICALS INC

CPIX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3144,521,431-2,791,993-2,836,128-0.19
2024-12-3137,867,945-6,432,409-6,479,770-0.46
2023-12-3139,552,507-9,554,661-6,279,320-0.44
2022-12-3142,010,949-5,704,929-5,570,241-0.38
2021-12-3135,045,259-7,677,420-3,507,587-0.24

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-03-18Galante Joseph C1,800
2026-03-18Herman James LVP and Chief Compliance Office2,500
2026-03-18Brown Martin S JR1,800
2026-03-18Jones James1,800
2026-03-18Krogulski Kenneth1,800
2026-03-18Krogulski Kenneth4,000
2026-03-18Young Caroline1,800
2026-03-18Anthony Todd M.Vice Pres Organizational Dev3,000
2026-03-18Bitterman Chris T.Vice Pres Sales & Marketing3,000
2026-03-18Hamm John M.VP Chief Financial Officer3,000
2026-03-18KAZIMI A JChairman and CEO100,000
2026-03-16KAZIMI A JChairman and CEO5,845

8-K events

FiledItems
2026-09-11Submission of matters to a vote
2026-08-28Regulation FD disclosure
2026-08-04Results of operations · Financial statements and exhibits
2026-07-13Other events
2026-07-01Entry into a material agreement · Termination of a material agreement · Completed acquisition or disposition of assets · Officer or director change · Other events · Financial statements and exhibits
2026-06-25Submission of matters to a vote
2026-05-05Results of operations · Financial statements and exhibits
2026-04-24Submission of matters to a vote
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.